Intellia Therapeutics, Inc. vs UnitedHealth Group Incorporated — Stock Comparison

NTLA
Intellia Therapeutics, Inc.
$13.26
▼ 1.63%
vs
UNH
UnitedHealth Group Incorporated
$368.78
▼ 0.46%
Q·Score Winner
UnitedHealth Group Incorporated
UNH6.3/10vs 6.2/10

Q·Score Breakdown

6.2
Neutral
Overall
6.3
Neutral
1.6
Quality
6.2
9.7
Health
5.3
7.8
Growth
5.1
6.9
Valuation
7.3
6.4
Sentiment
8.1
NTLA

Clean balance sheet with low leverage (0.1× debt-to-equity).

low return on equity (-53%).

UNH

82% of 28 covering analysts have a positive rating.

limited growth momentum.

Analyst Consensus

BUY
Target $26.71 (+101.5%)
21 analysts
BUY
Target $387.27 (+5.0%)
26 analysts

Fundamentals

NTLA
UNH
Trailing P/E
27.9×
-4.6×
Forward P/E
17.8×
0.0%
Profit Margin
2.7%
0.0%
Gross Margin
18.8%
-53.5%
ROE
12.2%
78.8%
Revenue Growth
2.0%
Earnings Growth
0.7%
1.99
Beta
0.41
Price / Book
$1.6B
Market Cap
$334.9B
$7 – $28
52-Week Range
$235 – $410

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →